Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis

Molecular Nutrition and Food Research

Volumn 55, Issue 12, 2011, Pages 1819-1828

  Lai, Ching Shu ^a   Wu, Jia Ching ^a   Yu, Shih Feng ^a   Badmaev, Vladimir ^b   Nagabhushanam, Kalyanam ^c   Ho, Chi Tang ^d   Pan, Min Hsiung ^a  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b Laboratory of Applied Pharmacology   (United States)

^c SABINSA CORPORATION   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Aberrant crypt foci; Anti inflammation; Azoxymethane; Curcumin; Tetrahydrocurcumin

Indexed keywords

ANTINEOPLASTIC AGENT; AZOXYMETHANE; BETA CATENIN; CATNB PROTEIN, MOUSE; CURCUMIN; DRUG DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; TETRAHYDROCURCUMIN; WNT1 PROTEIN; WNT1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COLON; COLON TUMOR; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECT; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; BETA CATENIN; BLOTTING, WESTERN; COLON; COLONIC NEOPLASMS; CURCUMIN; DOWN-REGULATION; GLYCOGEN SYNTHASE KINASE 3; MALE; MICE; MICE, INBRED ICR; PHOSPHORYLATION; WNT1 PROTEIN;

EID: 82955170666     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100290     Document Type: Article

References (32)

1. Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S. et al., Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007, 28, 1765-1773.
2. Pan, M. H., Lin-Shiau, S. Y., Lin, J. K., Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem. Pharmacol. 2000, 60, 1665-1676.
3. Pan, M. H., Huang, T. M., Lin, J. K., Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 1999, 27, 486-494.
4. Sugiyama, Y., Kawakishi, S., Osawa, T., Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem. Pharmacol. 1996, 52, 519-525.
5. Osawa, T., Sugiyama, Y., Inayoshi, M., Kawakishi, S., Antioxidative activity of tetrahydrocurcuminoids. Biosci. Biotechnol. Biochem. 1995, 59, 1609-1612.
6. Huang, M. T., Ma, W., Lu, Y. P., Chang, R. L. et al., Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 1995, 16, 2493-2497.
7. Kim, J. M., Araki, S., Kim, D. J., Park, C. B. et al., Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1, 2-dimethylhydrazine initiation. Carcinogenesis 1998, 19, 81-85.
8. Pan, M. H., Lai, C. S., Wu, J. C., Ho, C. T., Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol. Nutr. Food Res. 2011, 55, 32-45.
9. Janakiram, N. B., Rao, C. V., Molecular markers and targets for colorectal cancer prevention. Acta Pharmacol. Sin. 2008, 29, 1-20.
10. Fearon, E. R., Vogelstein, B., A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
11. Takayama, T., Katsuki, S., Takahashi, Y., Ohi, M. et al., Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med. 1998, 339, 1277-1284.
12. Segditsas, S., Tomlinson, I., Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006, 25, 7531-7537.
13. Li, J., Mizukami, Y., Zhang, X., Jo, W. S., Chung, D. C., Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta. Gastroenterology 2005, 128, 1907-1918.
14. Giehl, K., Oncogenic Ras in tumour progression and metastasis. Biol. Chem. 2005, 386, 193-205.
15. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., Hemmings, B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378, 785-789.
16. Li, Z., Zhou, Z., Welch, D. R., Donahue, H. J., Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin. Exp. Metastasis 2008, 25, 893-901.
17. Kanczuga-Koda, L., Sulkowski, S., Lenczewski, A., Koda, M. et al., Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J. Clin. Pathol. 2006, 59, 429-433.
18. Xia, X., Batra, N., Shi, Q., Bonewald, L. F. et al., Prostaglandin promotion of osteocyte gap junction function through transcriptional regulation of connexin 43 by glycogen synthase kinase 3/beta-catenin signaling. Mol. Cell. Biol. 2010, 30, 206-219.
19. Kundu, J. K., Surh, Y. J., Inflammation: gearing the journey to cancer. Mutat. Res. 2008, 659, 15-30.
20. Takahashi, M., Wakabayashi, K., Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci. 2004, 95, 475-480.
21. Bieri, J. G., AIN-76 diet. J. Nutr. 1979, 109, 925-926.
22. McLellan, E. A., Medline, A., Bird, R. P., Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res. 1991, 51, 5270-5274.
23. Reynoso-Camacho, R., Gonzalez-Jasso, E., Ferriz-Martinez, R., Villalon-Corona, B. et al., Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PKB, and beta-catenin proteins. Nutr. Cancer 2011, 63, 39-45.
24. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N. et al., Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275, 1787-1790.
25. Korinek, V., Barker, N., Morin, P. J., van, W. D. et al., Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275, 1784-1787.
26. Tetsu, O., McCormick, F., Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398, 422-426.
27. Easwaran, V., Lee, S. H., Inge, L., Guo, L. et al., Beta-catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 2003, 63, 3145-3153.
28. van der Heyden, M. A., Rook, M. B., Hermans, M. M., Rijksen, G. et al., Identification of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 1998, 111, 1741-1749.
29. Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J. et al., Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 1999, 59, 597-601.
30. Bing, R. J., Miyataka, M., Rich, K. A., Hanson, N. et al., Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin. Cancer Res. 2001, 7, 3385-3392.
31. Yeager, M., Harris, A. L., Gap junction channel structure in the early 21st century: facts and fantasies. Curr. Opin. Cell Biol. 2007, 19, 521-528.
32. Giardina, S. F., Mikami, M., Goubaeva, F., Yang, J., Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis. Biochem. Biophys. Res. Commun. 2007, 362, 747-752.